Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about MNMD

Recent news which mentions MNMD

< Previous 1 2
...
15 16 17 18 19 20 21 22 Next >
MindMed Launches Study Using Monitoring System For Psychedelic Experiences
Tickers MNMD
Tags Daniel R/ Karlin psychedelics MNMD
From Benzinga
Psychedelic Stock Gainers And Losers From January 17, 2022
Tickers ALID ATAI AWKNF CMPS
Tags GHRS FLHLF FTRP
From Benzinga
Cannabis Movers & Shakers: MindMed, Halo Collective, Item 9, PSYC, Flora Growth
Tickers AMZN CXXIF FLGC HCANF
Tags Leafly News Penny Stocks
From Benzinga
Psyched: Canada's Access To Psychedelic Medicines, Psilocybin No Cognitive Side Effects, Psilocybin Bill Washington
Tickers CMPS FLHLF MNMD
Tags MNMD psychedelics Benzinga
From Benzinga
MindMed Completes Phase 1 Clinical Trial Of Non-Hallucinogenic Proprietary Derivative Of Ibogaine
Tickers MNMD
Tags Robert Barrow Small Cap Market News
From Benzinga
2021 Was The Year Psychedelics Conquered Capitalism...Or Is It The Other Way Around?
Tickers ATAI CMPS MNMD PSIL
Tags Benzinga MNMD Topics
From Benzinga
Cannabis Movers & Shakers: MindMed & Trulieve Management Shake-Ups, Credex Corp & CapStone Bolster Leadership Teams
Tickers CRDX CURLF MNMD TCNNF
Tags Entrepreneurship appointments Markets
From Benzinga
MindMed Shares Update On Phase 2b Trials of LSD For Treating Generalized Anxiety Disorder
Tickers MNMD
Tags FDA Robert Barrow Small Cap
From Benzinga
MNMD Stock: The Latest Psychedelic Drug News MindMed Fans Should Watch
Tickers MNMD
Tags MNMD Today's Market NASDAQ:MNMD
From InvestorPlace
MindMed Advances Phase 2a LSD Microdose Trial For Adult ADHD
Tickers MNMD
Tags Markets Market News LSD
From Benzinga
Mind Medicine to Study Effect of Time on LSD Microdosing
Tickers MNMD MYCOF
Tags Market News InvestorBrandNetwork MYCOF
From Benzinga
Cannabis Movers & Shakers: HEXO, Agrify, MindMed, KetamineOne
Tickers AGFY CGC CURR HEXO
Tags appointments Market News CURR
From Benzinga
MindMed Names Robert Barrow As CEO & Director, Announces Management Shake-Ups
Tickers CRLBF MNMD
Tags Perry Dellelce Benzinga CRLBF
From Benzinga
Trip to Sustainability? This Company Is Developing Synthetic Psychedelics To Attempt to Fight Mental Illness
Tickers ATAI MCUR MNMD
Tags Market News Cannabis MCUR
From Benzinga
Fintech Focus For December 13, 2021
Tickers AXAHY BAC COIN GS
Tags VYGVF Market News COIN
From Benzinga
EXCLUSIVE: MindMed CEO Rob Barrow On Growth Aspirations, Development Pipeline
Tickers MNMD NDAQ
Tags NDAQ Market News Small Cap
From Benzinga
Psilera's DMT-Derived Drug Sees Positive Results in Pre-Clinical Study
Tickers ATAI CYBN MNMD
Tags MNMD Biotech Benzinga
From Benzinga
FDA Shows Support For Development Of MindMed's Session Monitoring System
Tickers MNMD
Tags MNMD Biotech Benzinga
From Benzinga
This Company Is Making Synthetic Psychedelics With a Goal To Combat Mental Illness
Tickers ATAI MCUR MCURF MNMD
Tags Market News Cannabis MCURF
From Benzinga
MNMD Stock Pops Higher After MindMed Unveils ‘Psychedelic’ Data
Tickers MNMD
Tags Market News Today's Market MNMD
From InvestorPlace
Antidepressants Can Be Used During Psilocybin Treatment, A New MindMed & Liechti Lab Study Finds
Tickers MNMD
Tags Study Markets Education
From Benzinga
3 Psychedelic Stocks for Potential Out-of-This-World Gains
Tickers FTRP MNMD PSIL
Tags MNMD Stocks to Buy FTRP
From InvestorPlace
MindMed Q3 Earnings: Big Improvement, Kicks Off Sleep & Cognitive Study With Dose Low-Dose LSD
Tickers MNMD
Tags Penny Stocks News Market News
From Benzinga
Cannabis Movers & Shakers: Mind Medicine, Avant Brands, Delic, Agrify, Ascend Wellness, Pure Beauty
Tickers AAWH MMNFF MNMD
Tags Robert Barrow Movers & Shakers General
From Benzinga
Behind the Wall: Psychedelics Have “Absolutely Transformational” Potential
Tickers CMPS FTRP MNMD
Tags MNMD FTRP Market Insight, Financial Articles
From InvestorPlace
How This Company Is Using Psychedelic Medicines and Therapies to Treat Addiction and Mental Illness
Tickers MNMD TSLA
Tags MMED Partner Content Markets
From Benzinga
Magic Mushrooms and Ecstasy: New Treatment For Autism Spectrum Disorders?
Tickers MNMD NOVA
Tags NOVA Small Cap General
From Benzinga
Psyched: MindMed's MDMA Program For Autism, Small Pharma's New Patent, NovaMentis' Orphan Drug Designation
Tickers AWKNF CYBN DELCF MCURF
Tags Wavepaths CYBN DELCF
From Benzinga
Biotech Companies Are Embracing the Growing Psychedelic Drug Market To Confront a Global Increase in Depression and Anxiety
Tickers KTTA MNMD SEEL
Tags Partner Content General Small Cap
From Benzinga
These 4 Psychedelic Biotech Stocks Are Leading the Pack
Tickers ATAI CMPS CYBN MNMD
Tags CMPS MNMD ATAI
From Motley Fool
< Previous 1 2
...
15 16 17 18 19 20 21 22 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.